{
    "Trade/Device Name(s)": [
        "Tina-quant Transferrin ver.2 (urine application)"
    ],
    "Submitter Information": "Roche Diagnostics Operations (RDO)",
    "510(k) Number": "K182095",
    "Predicate Device Reference 510(k) Number(s)": [
        "K053075"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DDG"
    ],
    "Summary Letter Date": "August 1, 2018",
    "Summary Letter Received Date": "August 3, 2018",
    "Submission Date": "November 1, 2018",
    "Regulation Number(s)": [
        "21 CFR 866.5880"
    ],
    "Regulation Name(s)": [
        "Transferrin immunological test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Transferrin"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [
        ""
    ],
    "Instrument(s)/Platform(s)": [
        "Roche/Hitachi cobas c systems",
        "cobas c 501 analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Immunoturbidimetric assay"
    ],
    "Methodologies": [
        "Immunochemical detection",
        "Immunoturbidimetry"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for Tina-quant Transferrin ver.2 (urine application) immunoturbidimetric assay for quantitative determination of transferrin in human urine using Roche/Hitachi cobas c systems",
    "Indications for Use Summary": "In vitro test for the quantitative determination of transferrin in human urine to aid in diagnosis of malnutrition, acute inflammation, infection, and red blood cell disorders including iron deficiency anemia",
    "fda_folder": "Immunology"
}